Early cost–utility analysis of genetically guided therapy for patients with drug‐resistant epilepsy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early cost–utility analysis of genetically guided therapy for patients with drug‐resistant epilepsy

Published:2022-10-17 Issue:12 Volume:63 Page:3111-3121
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Gordon Louisa G.¹²³^ORCID,Elliott Thomas M.¹,Bennett Carmen⁴,Hollway Georgina¹³⁵,Waddell Nicola¹³⁵,Vadlamudi Lata⁴⁶^ORCID

Affiliation:

1. QIMR Berghofer Medical Research Institute Brisbane Queensland Australia

2. School of Nursing and Cancer and Palliative Care Outcomes Centre Queensland University of Technology Brisbane Queensland Australia

3. Faculty of Medicine University of Queensland Brisbane Queensland Australia

4. University of Queensland Centre for Clinical Research University of Queensland Brisbane Queensland Australia

5. genomiQa Brisbane Queensland Australia

6. Department of Neurology Royal Brisbane and Women's Hospital Brisbane Queensland Australia

Funder

Queensland Government

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.17408

Reference48 articles.

1. World Health Organization.Epilepsy.2022[cited 2022 Aug 25]. Available from:https://www.who.int/news‐room/fact‐sheets/detail/epilepsy

2. The global cost of epilepsy: a systematic review and extrapolation;Begley C;Epilepsia,2022

3. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology

4. Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs

5. Early Identification of Refractory Epilepsy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The long odyssey for the DEE‐CDKL5 diagnosis: A call for action;Epilepsia Open;2024-09-09

2. Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications;Pharmacogenomics;2024-01

3. Gene panel to guide antiseizure medication prescribing: Does the cost justify the benefits?;Epilepsia;2022-10-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3